Synovial fluid neutrophils in oligoarticular juvenile idiopathic arthritis have an altered phenotype and impaired effector functions

Table 1 Description of patient cohort

Pat#	Sex	Disease duration (months)	Age (years)	Treatment	Uveitis	ANA	Phenotype analysis	Functional assay	Biopsy	Follow-up sample	Time to follow-up (months)	Treatment at follow-up
1*	M	132	15	No	No	Pos	Yes	No	No	No
2	F	26	7	NSAID	No	Pos	Yes	No	No	No
3*	F	88	11	No	No	Pos	Yes	Yes	No	Yes	40	No
4*	F	0	6	NSAID	Yes	Pos	Yes	Yes	Yes	No
5*	F	3	11	NSAID	Yes	Pos	Yes	Yes	No	Yes	34	NSAID
6*	F	49	7.5	NSAID	No	Pos	Yes	No	No	Yes	31	TNFi
7*	F	48	16.5	No	Yes	Pos	Yes	Yes	No	No
8*	F	2	3.5	No	No	Pos	Yes	Yes	Yes	No
9*	F	1	15	NSAID	No	Pos	Yes	Yes	No	Yes	20	Mtx, NSAID
10*	M	1	12	NSAID	No	Neg	Yes	Yes	No	No
11	M	4	10	NSAID	No	Pos	Yes	Yes	No	Yes	19	Mtx
12*	F	0	2	No	No	Pos	Yes	Yes	No	Yes	16	Mtx
13	F	144	17	NSAID	No	Neg	Yes	Yes	No	No
14*	F	1	13	NSAID	No	Neg	Yes	Yes	No	No
15	M	2	4	NSAID	No	Pos	Yes	No	No	No
16	M	0	6	NSAID	No	Pos	Yes	Yes	No	No
17*	F	1	11	No	No	Neg	Yes	Yes	Yes	No
18	F	50	5	Mtx	Yes	Pos	No	No	Yes	No

Clinical and sample data. Disease duration is calculated as months since the date of diagnosis
Abbreviations: TNFi TNF inhibitor, Mtx methotrexate
*Patients are also included in Schmidt et al. [9]

ISSN: 1478-6362